We found that spleen IL-6 levels were higher in low dose (5 mg/kg) (G2) and high dose (10 mg/kg) (G3) mematine groups when compared with tumor control group (G1) (p = 0.0204) (Figure 4, Table 2). Here, IL6 is linked to neoplasm.